This inventor holds 4 USPTO granted patents. Top assignee: Smithkline Beecham Corporation. Active years: 2004-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2006
Title: Michael J Bower: Innovator in Quinazoline Compounds
Introduction
Michael J Bower is a notable inventor based in Audubon, PA (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of quinazoline compounds. With a total of 4 patents to his name, Bower's work focuses on innovative therapeutic solutions.
Latest Patents
Among his latest patents are the following: "3,4-Dihydro-(1H) quinazolin-2-one compounds as CSBP/P38 kinase inhibitors" and "Novel substituted quinazoline compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors." These patents highlight his commitment to advancing medical treatments through chemical innovation.
Career Highlights
Bower is currently associated with SmithKline Beecham Corporation, where he continues to push the boundaries of pharmaceutical research. His work has been instrumental in developing new therapies that target specific kinases, which are crucial in various disease processes.
Collaborations
Throughout his career, Bower has collaborated with esteemed colleagues such as Jerry Leroy Adams and Don Edgar Griswold. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Michael J Bower's contributions to the field of medicinal chemistry through his patents and collaborations underscore his role as a leading inventor. His work continues to pave the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile